InsidersTradesSigma
Vicore Pharma Holding AB Stock: price and management transactions · Finland · FIN-FSA
Follow the Vicore Pharma Holding AB share price and the full directors' dealings record of the company, a listed equity based in Finland. Shares trade on FI FI, under the authority of FIN-FSA. Operating in the Health Care sector, Vicore Pharma Holding AB has published 3 insider filings. Market capitalisation: €3.8bn. The latest transaction was disclosed on 7 July 2026 (Purchase). Among the most active insiders: Hans Lennart Jeppsson. All data is free.
3
Insider Decl.
0
Thresholds
€161,082
3 ops.
Buy Volume
·
0 ops.
Sell Volume
19Σ signal
Fundamental score
Ranked 19,876 of 26,153 companies
33.8
score / 100
Value15
Quality53
FCF yld-10%
Earn yld-13%
EV/EBITDA·
ROE-47%
Gross mgn100%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 7 July 2026
Declarations3 total
3 shares@ €13.90DepåbevisFI:csv-5d0997c4ef5a13bdfb2e
Ideal exit: 2 Apr 2027 (T+270)
160,220 shares@ SEK 10.56030.0051% mcap100.0% of flowAktieFI:csv-0c7f17d1fd70b47c327b
Ideal exit: 9 Mar 2027 (T+270)
10,000 shares@ €0.70370.0002% mcap100.0% of flowAktieFI:A003O165-1
Ideal exit: 2 Feb 2026 (T+270)
3 of 3 declarations
About Vicore Pharma Holding AB
Vicore Pharma Holding AB is a biopharmaceutical company focused on developing treatments for respiratory diseases. It is listed on the Stockholm Stock Exchange (XSTO).